版本:
中国

BRIEF-Clinigen and Onxeo initiate managed access programme for belinostat in Europe for patients with peripheral T-cell lymphoma (PTCL)

April 24 Onxeo SA:

* Clinigen and co initiate managed access programme for belinostat in Europe for patients with peripheral T-cell lymphoma (PTCL) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐